TY - JOUR
AU - Vasileiou, Eleftheria
AU - Shi, Ting
AU - Kerr, Steven
AU - Robertson, Chris
AU - Joy, Mark
AU - Tsang, Ruby SM
AU - McGagh, Dylan
AU - Williams, John
AU - Hobbs, Richard
AU - de Lusignan, Simon
AU - Bradley, Declan T.
AU - O'Reilly, Dermot
AU - Murphy, Siobhán
AU - Chuter, Antony
AU - Beggs, Jillian
AU - Ford, David V.
AU - Orton, Chris
AU - Akbari, Ashley
AU - Bedston, Stuart
AU - Davies, Gareth
AU - Griffiths, Lucy J.
AU - Griffiths, Rowena
AU - Lowthian, Emily
AU - Lyons, Jane
AU - Lyons, Ronan A.
AU - North, Laura
AU - Perry, Malorie
AU - Torabi, Fatemeh
AU - Pickett, James
AU - Jim McMenamin
AU - McCowan, Colin
AU - Agrawal, Utkarsh
AU - Wood, Rachael
AU - Stock, Sarah J.
AU - Moore, Emily
AU - Henery, Paul M.
AU - Simpson, Colin R
AU - Sheikh, Aziz
PY - 2022
DA - February
TI - Investigating the uptake, effectiveness and safety of COVID-19 vaccines: protocol for an observational study using linked UK national data
JO - BMJ Open
VL - 12
IS - 2
DO - https://doi.org/10.1136/bmjopen-2021-050062
AB - Introduction: The novel coronavirus SARS-CoV-2, which emerged in December 2019, has caused millions of deaths and severe illness worldwide. Numerous vaccines are currently under development of which a few have now been authorised for population-level administration by several countries. As of 20 September 2021, over 48 million people have received their first vaccine dose and over 44 million people have received their second vaccine dose across the UK. We aim to assess the uptake rates, effectiveness, and safety of all currently approved COVID-19 vaccines in the UK.
PB - BMJ Publishing Group
UR - http://hdl.handle.net/10023/24939
KW - Coronavirus (COVID-19)
KW - Research methods
ER